ViiV Healthcare Company et al. v. Pharmascience Inc.
2024
T-156-24
Pending
6(1) PMNOC
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,606,282 (dolutegravir).
Counsel to:
Pharmascience Inc.
The decision is reported
here.